Nuvalent (NUVL) Cash from Operations (2020 - 2026)
Nuvalent (NUVL) posted Cash from Operations of 92399000.0 for Q1 2026, down 26.01% on a QoQ basis from 73328000.0 in Q4 2025, and down 68.55% year-over-year from 293765909.59 in Q1 2025.
Nuvalent (NUVL) Cash from Operations (2020 - 2026) Analysis & Trends
Nuvalent's Cash from Operations history runs 7 years deep, the most recent figure standing at 92399000.0 for Q1 2026.
- Quarterly Cash from Operations fell 68.55% year-over-year to 92399000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 312787000.0 (down 53.48% YoY) and the FY2025 annual result came in at 275209000.0, down 48.71% from the prior year.
- Cash from Operations was 92399000.0 for Q1 2026 at Nuvalent, down from 73328000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 13542000.0 in Q1 2022 and bottomed at 92399000.0 in Q1 2026.
- A 5-year average of 42198941.18 and a median of 36087000.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2022 — Cash from Operations plunged 128.25% — and 2025, when it dropped 18.27%.
- Nuvalent's Cash from Operations stood at 17779000.0 in 2022, then slumped by 69.91% to 30209000.0 in 2023, then slumped by 105.24% to 62000000.0 in 2024, then fell by 18.27% to 73328000.0 in 2025, then declined by 26.01% to 92399000.0 in 2026.
- Business Quant data shows NUVL's Cash from Operations at 92399000.0 in Q1 2026, 73328000.0 in Q4 2025, and 70462000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | -92.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -92.40 Mn |
| Mar 31, 2026 | -92.40 Mn |
| Dec 31, 2025 | -73.33 Mn |
| Dec 31, 2025 | -73.33 Mn |
| Sep 30, 2025 | -70.46 Mn |
| Sep 30, 2025 | -70.46 Mn |
| Jun 30, 2025 | -76.60 Mn |
| Jun 30, 2025 | -76.60 Mn |
| Mar 31, 2025 | -54.82 Mn |
| Mar 31, 2025 | -54.82 Mn |
| Dec 31, 2024 | -62.00 Mn |
| Dec 31, 2024 | -62.00 Mn |
| Sep 30, 2024 | -45.82 Mn |
| Sep 30, 2024 | -45.82 Mn |
| Jun 30, 2024 | -41.16 Mn |
| Jun 30, 2024 | -41.16 Mn |
| Mar 31, 2024 | -36.09 Mn |
| Mar 31, 2024 | -36.09 Mn |
| Dec 31, 2023 | -30.21 Mn |
| Dec 31, 2023 | -30.21 Mn |